LTBR and neoplasm: LIGHT/LTβR signaling normalizes tumor vasculature via LTβR-dependent ICAM, vascular cell adhesion protein (VCAM), and smooth muscle actin (SMA) expression, and it facilitates infiltration of immune effector cells.